Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer

QR Code

Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer

© 2015 Cancer Research UK Background:Foxp3+ regulatory T cells (Tregs) play a vital role in preventing autoimmunity, but also suppress antitumour immune responses. Tumour infiltration by Tregs has strong prognostic significance in colorectal cancer, and accumulating evidence suggests that chemothera...

Full description

Bibliographic Details
Main Authors:	McCoy, M., Hemmings, C., Miller, T., Austin, S., Bulsara, M., Zeps, Nikolajs, Nowak, A., Lake, R., Platell, C.
Format:	Journal Article
Published:	2015
Online Access:	http://hdl.handle.net/20.500.11937/27135

Similar Items

Neoadjuvant chemoradiotherapy for rectal cancer: how important is tumour regression?
by: McCoy, M., et al.
Published: (2015)

Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response
by: McCoy, M., et al.
Published: (2017)

Manometric evaluation of anorectal function in patients treated with neoadjuvant chemoradiotherapy and total mesorectal excision for rectal cancer
by: De Nardi, Paola, et al.
Published: (2017)

Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer
by: Salama, P., et al.
Published: (2009)

SPARC, FOXP3, CD8 and CD45 correlation with disease recurrence and long-term disease-free survival in colorectal cancer
by: Chew, A., et al.
Published: (2011)

Rare Cancers
by: Zeps, Nikolajs, et al.
Published: (2015)

Influence of local recurrence on survival in patients with rectal cancer
by: Platell, Cameron, et al.
Published: (2014)

The influence of ppary ligands on the expression of FOXP3 in natural t-regulatory cells in balb/c and type 1 diabetes mouse model
by: Zulkafli, Nor Effa Syazuli
Published: (2015)

Weight loss in post-chemoradiotherapy head and neck cancer patients
by: Abu Zaid, Zalina, et al.
Published: (2022)

The Effect Of Peroxisome Proliferatorr Activated Receptor Gamma (Pparγ) On The Expression Of Foxp3, Tigit, Icos And Histone Proteins In Natural T-Regulatory Cells
by: Lee, Pei Chen
Published: (2019)

Preoperative CEA as a predictor of response to neoadjuvant radiotherapy
by: Mino, Jeffrey, et al.
Published: (2016)

Expression of ZENK and FOXP1 gene in a brain of a parrot
by: Yazid, Nurul Afiqah
Published: (2015)

Investigating radiation responsiveness in rectal cancer
by: Hassall, James
Published: (2021)

Rectal polyposis in mucosal prolapse syndrome
by: Wong, Yin Ping, et al.
Published: (2022)

The colorectal surgeon’s personality may influence the rectal anastomotic decision
by: Moug, Susan, et al.
Published: (2018)

FOXP1 expression correlates with better prognosis in invasive breast cancer including the ER-positive luminal subtype
by: Joseph, C., et al.
Published: (2017)

Emerging Mechanisms of Physical Exercise Benefits in Adjuvant and Neoadjuvant Cancer Immunotherapy.
by: Casciano, Fabio, et al.
Published: (2024)

Evaluation of tualang honey and propolis on vaginal flora in locally advanced cervical cancer patients undergoing chemoradiotherapy
by: Safruddin, Engku Ibrahim Syubli Engku
Published: (2018)

Tumour banking as part of routine clinical practice
by: Platell, C., et al.
Published: (2010)

Rectal neuroendocrine tumor: a case series
by: Kamarudin, Zalikha, et al.
Published: (2017)

Impact of obesity on cost of rectal cancer surgery
by: Elagili, Faisal, et al.
Published: (2014)

Resistance training and the risk of colon and rectal cancers
by: Boyle, T., et al.
Published: (2012)

Concurrent bloat and rectal prolapse in a cow
by: Abdullah, Faez Firdaus Jesse, et al.
Published: (2014)

Comprehensive molecular characterization of human colon and rectal cancer
by: Muzny, D., et al.
Published: (2012)

Abnormal T regulatory cells (Tregs: FOXP3+, CTLA-4+), myeloid-derived suppressor cells (MDSCs: monocytic, granulocytic) and polarised T helper cell profiles (Th1, Th2, Th17) in women with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC) and surgery: failure of abolition of abnormal treg profile with treatment and correlation of treg levels with pathological response to NAC
by: Verma, Chandan, et al.
Published: (2013)

CD10 stromal expression in phyllodes tumours
by: Nur Syahrina, R, et al.
Published: (2011)

Effect of constant and intermittent heat stress on rectal temperature and implantation sites in the rat
by: Sulong, Adnan, et al.
Published: (1986)

Application of 3D seismic in the delineation of U bearing structures at Ranger 3 Deeps
by: McCoy, A., et al.
Published: (2010)

Consent to Donate Surgical Biospecimens for Research: Perceptions of People With Colorectal Cancer
by: Williams, A., et al.
Published: (2015)

Developing stromal instructive niches to promote wound healing
by: Latif, Arsalan
Published: (2021)

The potential of marrow stromal cells in stem cell therapy
by: Kicic, Anthony, et al.
Published: (2001)

Differentiation of marrow stromal cells into photoreceptors in the rat eye
by: Kicic, Anthony, et al.
Published: (2003)

Gastrointestinal Stromal Tumour: cause of Obscure Gastrointestinal Bleeding.
by: Ngow, Harris Abdullah, et al.
Published: (2010)

Genotyping of single nucleotide polymorphisms (SNPs) of CTLA-4 and FOXP3 genes in lymphatic filariasis and schistosomiasis.
by: Idris, Zulkarnain Md
Published: (2011)

Comparing perineal repairs for rectal prolapse: Delorme versus Altemeier
by: Faisal, Elagili, et al.
Published: (2015)

Subcutaneous metastases from rectal carcinoma: A case report
by: Jasman JW,, et al.
Published: (2011)

Gut microflora: association and risk of sigmoid colon and rectal cancer
by: Mohamed Sikandar, Faizah
Published: (2015)

Caspase-cleaved cytokeratin-18 and tumour regression in gastro-oesophageal adenocarcinomas treated with neoadjuvant chemotherapy
by: Fareed, Khaleel R., et al.
Published: (2012)

Comparing neoadjuvant nab-paclitaxel vs paclitaxel both followed by anthracycline regimens in women with ERBB2/ HER2-negative breast cancer-the evaluating treatment with neoadjuvant abraxane (ETNA) trial a randomized phase 3 clinical trial
by: Gianni, L., et al.
Published: (2018)

School Counselors' Knowledge and Involvement Concerning Gifted and Talented Students
by: Carlson, N., et al.
Published: (2017)